This study further reiterates the clinical findings associated with ATAD3A pathogenic variation, including developmental delay, hypotonia, congenital cataracts, hypertrophic cardiomyopathy, and cerebellar atrophy. Here, ATAD3A is linked to hypertrophic cardiomyopathy.